Difei Lu

519 total citations
34 papers, 385 citations indexed

About

Difei Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Oncology. According to data from OpenAlex, Difei Lu has authored 34 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Difei Lu's work include Cancer Immunotherapy and Biomarkers (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Neuroblastoma Research and Treatments (4 papers). Difei Lu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Neuroblastoma Research and Treatments (4 papers). Difei Lu collaborates with scholars based in China, United States and Netherlands. Difei Lu's co-authors include Gianni Tartari, Kenji Taniguchi, V. Ramanathan, Mian Chin, C. S. Hsu, Yingying Ma, K. M. Lau, Renjian Zhang, B. N. Holben and Junqing Zhang and has published in prestigious journals such as Annals of Internal Medicine, The Journal of Clinical Endocrinology & Metabolism and Bulletin of the American Meteorological Society.

In The Last Decade

Difei Lu

28 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Difei Lu China 9 208 204 42 35 34 34 385
Peiyan Chen China 14 225 1.1× 183 0.9× 41 1.0× 16 0.5× 109 3.2× 40 540
Antonio García‐Méndez Spain 8 147 0.7× 144 0.7× 17 0.4× 7 0.2× 85 2.5× 21 393
Seema Singh India 9 159 0.8× 156 0.8× 16 0.4× 21 0.6× 29 0.9× 23 385
Chen Zhou China 8 148 0.7× 181 0.9× 16 0.4× 11 0.3× 21 0.6× 25 361
Yunyao Li United States 12 159 0.8× 163 0.8× 23 0.5× 65 1.9× 55 1.6× 36 373
H-J Wang China 8 84 0.4× 77 0.4× 36 0.9× 20 0.6× 144 4.2× 11 285
Hongke Cai China 12 118 0.6× 129 0.6× 147 3.5× 16 0.5× 193 5.7× 43 560
Ting Lü China 13 47 0.2× 39 0.2× 16 0.4× 125 3.6× 73 2.1× 40 428

Countries citing papers authored by Difei Lu

Since Specialization
Citations

This map shows the geographic impact of Difei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Difei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Difei Lu more than expected).

Fields of papers citing papers by Difei Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Difei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Difei Lu. The network helps show where Difei Lu may publish in the future.

Co-authorship network of co-authors of Difei Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Difei Lu. A scholar is included among the top collaborators of Difei Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Difei Lu. Difei Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yiqun, Changxi Zhang, Lingyi Xu, et al.. (2025). Closed‐Loop Bioelectronic Artificial Pancreas Patch for Continuous Monitoring and Regulation of Blood Glucose in Diabetic Rats and Pigs. Advanced Science. 12(44). e03536–e03536.
2.
Shao, Wen, et al.. (2025). Endocrine Adverse Reactions of Tyrosine Kinase Inhibitors in Combination With Immune Checkpoint Inhibitors. The Journal of Clinical Endocrinology & Metabolism. 110(11). e3857–e3865. 1 indexed citations
3.
Yu, Ying, Chen Suo, Hui Wang, et al.. (2025). Palliative Care Educational App for Family Caregivers of Homebound Patients With Incurable Cancer. Annals of Internal Medicine. 178(12). 1737–1751.
4.
Zhou, Minqi, et al.. (2025). Hydrogen sulphide alleviates platelet dysfunction in patients with type 2 diabetes. Journal of Thrombosis and Thrombolysis. 58(3). 433–442.
5.
Lu, Difei, Xiaohui Guo, Liyong Zhu, et al.. (2024). Efficacy and safety of intragastric expandable oral capsules in adults with overweight or obesity: A randomized, double‐blind, placebo‐controlled trial. Diabetes Obesity and Metabolism. 26(4). 1224–1233. 3 indexed citations
6.
7.
Lu, Difei, et al.. (2024). Immune checkpoint inhibitor-associated new-onset hypophysitis: a retrospective analysis using the FAERS. Endocrine. 86(1). 342–348. 2 indexed citations
8.
Yi, Tieci, Difei Lu, Yonggang Cui, et al.. (2024). 68Ga-pentixafor PET/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling. Molecular Imaging and Biology. 27(1). 142–150. 3 indexed citations
9.
Lu, Difei, Rui Zheng, Ang Li, & Junqing Zhang. (2024). Efficacy of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on proteinuria and weight in a diabetes cohort. World Journal of Diabetes. 16(2). 98552–98552. 1 indexed citations
10.
Yuan, Xiaoyong, Difei Lu, Lihui Yang, et al.. (2023). Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study. Open Life Sciences. 18(1). 20220740–20220740.
11.
Lu, Difei, et al.. (2022). Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS. Journal of Endocrinological Investigation. 45(11). 2131–2137. 11 indexed citations
12.
Yu, Na, Yuxin Wang, Bin Zhou, et al.. (2022). The Association of Plasma Trimethylamine N-Oxide with Coronary Atherosclerotic Burden in Patients with Type 2 Diabetes Among a Chinese North Population. Diabetes Metabolic Syndrome and Obesity. Volume 15. 69–78. 8 indexed citations
13.
14.
Lu, Difei, et al.. (2022). Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis. International Journal of Endocrinology. 2022. 1–6. 2 indexed citations
15.
Lu, Difei, Aimei Dong, Junqing Zhang, & Xiaohui Guo. (2021). A novel GNAS mutation in pseudohypoparathyroidism type 1a in a Chinese man presented with recurrent seizure: a case report. BMC Endocrine Disorders. 21(1). 12–12. 4 indexed citations
16.
Zhang, Donghui, Jun Li, Lin Liu, et al.. (2018). Stage management efficiency and medication alternation analysis in a shared care clinic of diabetes. 10(7). 471–475. 1 indexed citations
17.
Ma, Xiaowei, Ge Bai, Difei Lu, et al.. (2017). Association between STK11 Gene Polymorphisms and Coronary Artery Disease in Type 2 Diabetes in Han Population in China. Journal of Diabetes Research. 2017. 1–6. 4 indexed citations
18.
Lu, Difei, Yin Wu, Gordon J. Harris, & Wenli Cai. (2015). Iterative mesh transformation for 3D segmentation of livers with cancers in CT images. Computerized Medical Imaging and Graphics. 43. 1–14. 9 indexed citations
19.
Debray, Thomas P. A., Hendrik Koffijberg, Difei Lu, et al.. (2012). Incorporating published univariable associations in diagnostic and prognostic modeling. BMC Medical Research Methodology. 12(1). 121–121. 14 indexed citations
20.
Augelli‐Szafran, Corinne E., H. X. Wei, Difei Lu, et al.. (2010). Discovery of Notch-Sparing γ-Secretase Inhibitors. Current Alzheimer Research. 7(3). 207–209. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peiyan Chen Breakdown of academic impact, for papers by Antonio García‐Méndez Breakdown of academic impact, for papers by Seema Singh Breakdown of academic impact, for papers by Chen Zhou Breakdown of academic impact, for papers by Yunyao Li Breakdown of academic impact, for papers by H-J Wang Breakdown of academic impact, for papers by Hongke Cai Breakdown of academic impact, for papers by Ting Lü
Rankless by CCL
2026